Skip to main content

Advertisement

Log in

Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract.

Objective: To assess (1) the long-term outcome of patients requiring renal replacement therapy (RRT) in terms of 6-month and 5-year mortality, (2) quality of life and (3) costs of the intensive care. Design: A retrospective observational cohort study. Setting: Twenty-three-bed multidisciplinary intensive care unit (ICU) in a tertiary care center. Patients and participants: Out of 3447 intensive care patients admitted, 62 patients with no end-stage renal failure required RRT. Interventions: None. Measurements and results: The incidence rate of acute renal failure (ARF) was 8/100,000 inhabitants/year. The majority of patients (71%) had ARF in conjunction with multiple organ failure. The mortality in the ICU and in the hospital was 34% and 45%, respectively. Mortality was 55% at 6 months and 65% at 5 years. Renal function recovered in 82% of the survivors during hospitalization. Loss of energy and limitations of physical mobility assessed by Nottingham Health Profile were the most frequently reported complaints at 6 months. Functional ability, as assessed by the Activities of Daily Living score was fairly good at 6 months. The cost per ARF 6-month survivor was $80 000. Conclusions: There was only a minor increase in mortality after discharge from hospital among patients treated for ARF in intensive care. The costs related to ARF in intensive care are high, but the almost complete physical and functional recovery seen in ARF survivors should be noted in cost-effective analyses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Final revision received: 27 June 2000

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Korkeila, M., Ruokonen, E. & Takala, J. Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med 26, 1824–1831 (2000). https://doi.org/10.1007/s001340000726

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001340000726

Navigation